← Leaderboards
Madhav C Menon
Yale University
$3,679,457
Attributed
$3,909,769
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,909,769 · 3
By mechanism
R01$3,449,144 · 2
R21$460,625 · 1
Top collaborators
- Shuta Ishibe2 shared
Most similar at Yale University
Same institution · by research overlap
- Stephen M Strittmatter$76,187,371
- Tong Wang Wang$8,061,119
- Lisa F Berkman$24,689,567
- Markus Mãschen$33,184,326
- Julie Goodwin$5,757,347
Others in their field
Other Emerging Leaders on “Nephrectomy”
- Mengxiao Yu · Clearnano, Inc.$2,363,386
- Tim Lautenschlaeger · Indiana University Indianapolis$2,316,477
- Jenny E. Kanter · University Of Washington$2,089,357
- Vera Hoffman · Reveal Pharma$1,744,391
- Wei Ling Lau · University Of California-Irvine$1,675,832
- Somayeh Besharat Shafiei · Roswell Park Cancer Institute Corp$1,564,438
Research focus
NephrectomyOverexpressionPhenotypeCohortIn VivoMorphometryPodocyteProteinuriaAlbuminuriaNovel TherapeuticsMorphologyActinsKnock-DownMediatingEnd Stage Renal FailurePathway InteractionsInjuryCytoskeletonBiopsyIn VitroFyn GeneDiffuseFoot ProcessGlomerulosclerosis
Grant awards (10)
Role of AMP-kinaseâ¯pathway in the regulation ofâ¯Minimal change disease-to-FSGS transition$497,321
R01 · FY2025 · DK · contact PI
Role of AMP-kinaseâ¯pathway in the regulation ofâ¯Minimal change disease-to-FSGS transition$502,883
R01 · FY2024 · DK · contact PI
Modelling mechanisms of progressive chronic kidney disease in APOL1 high-risk live-donors using BAC-Transgenic mice$209,375
R21 · FY2024 · AI · contact PI
Role of AMP-kinaseâ¯pathway in the regulation ofâ¯Minimal change disease-to-FSGS transition$555,565
R01 · FY2023 · DK · contact PI
Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneys$376,875
R01 · FY2023 · DK · contact PI
Modelling mechanisms of progressive chronic kidney disease in APOL1 high-risk live-donors using BAC-Transgenic mice$251,250
R21 · FY2023 · AI · contact PI
Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneys$376,875
R01 · FY2022 · DK · contact PI
Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneys$376,875
R01 · FY2021 · DK · contact PI
Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneys$381,375
R01 · FY2020 · DK · contact PI
Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneys$381,375
R01 · FY2019 · DK · contact PI